Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

Special Precautions Issued for Carpuject Syringes

The Food and Drug Administration (FDA) has alerted health care providers to the potential presence of cracked needle hubs and particulate in Carpuject Luer Lock Glass Syringe products.

Due to the critical drug shortage affecting Carpuject syringe products, its manufacturer, Hospira, is releasing the affected lots with special handling directions. Health care providers should inspect the Carpuject cartridges before use and discard them if the needle hub is cracked, the cartridge is discolored, or visible particulates are found. If no particulates are visible, providers as a precaution should attach a five-micron filter needle (BD REF 305200 or equivalent) to a sterile empty syringe before administering the drug.

Contact Hospira at 1.800.438.1985 to report adverse reactions or quality issues. FDA advises providers to report adverse reactions or quality problems associated with the affected products to the agency’s MedWatch Safety Information and Adverse Event Reporting Program.

Contact Senior Director of Policy Erin O’Malley at or 202.585.0127 with questions.


About the Author

Emily Schweich is a communications manager at America's Essential Hospitals.

Previous Next
Test Caption
Test Description goes like this